• Clinical Trials
  • Partnerships
  • Media
  • Careers
  • Contact
  • Science & Medicine
    • Scientific Focus
    • Pipeline
    • Medicines
  • Patients & Families
    • Diseases & Conditions
    • Patient Resources
    • Clinical Trials
    • Access to BylvayTM (odevixibat)
  • Responsibility
    • Access
    • Funding Requests
    • Disclosures
  • About Us
    • Leadership
    • Board of Directors
  • Investors
    • Press Releases
    • Events & Presentations
    • 2022 Annual Meeting
    • Corporate Governance & ESG
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • +
  • Science & Medicine
    • Scientific Focus
    • Pipeline
    • Medicines
  • Patients & Families
    • Diseases & Conditions
    • Clinical Trials
    • Patient Resources
    • Managed Access
  • Responsibility
    • Access
    • Funding Requests
    • Disclosures
  • About Us
    • Leadership
    • Board of Directors
    • Partnerships
  • Investors
    • Press Releases
    • Events & Presentations
    • 2021 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
  • Media
  • Contact
About Us

Leadership: Enterprise Team

  • Ron Cooper
    President and Chief Executive Officer
  • Simon Harford
    Chief Financial Officer
  • Pamela Stephenson
    Chief Commercial Officer
  • Jan Mattsson, Ph.D.
    Chief Scientific Officer, Managing Director (Sweden), and Co-Founder
  • Martha (Muffy) Carter
    Chief Regulatory Officer
  • Joan Connolly
    Chief Technology Officer
  • Jason Duncan
    Chief Legal Officer and General Counsel
  • Michelle Graham
    Chief Human Resources Officer
  • Constantine Chinoporos
    Chief Business Officer
  • Site Map
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Contact

© 2022 Albireo Pharma, Inc.

YOU ARE NOW LEAVING ALBIREOPHARMA.COM

The link you have selected will take you outside of Albireo Pharma’s corporate website. The site you will be entering is intended for U.S. audiences only.

Go Back
Continue

YOU ARE NOW LEAVING ALBIREOPHARMA.COM

You are now leaving Albireo Pharma’s corporate website. Albireo does not control or endorse the content of this external site.

Go Back
Continue

YOU ARE NOW LEAVING ALBIREOPHARMA.COM

The link you have selected will take you outside of Albireo Pharma’s corporate website.

Go Back
Continue
+